Skip to main content

Table 6 P value and 95% CI per comparison of conditions in the nicotinamide treatment analysis

From: Intravitreal MPTP drives retinal ganglion cell loss with oral nicotinamide treatment providing robust neuroprotection

Nicotinamide treatment

P value

95% CI

RBMPS+ cell soma count

Naïve control—vehicle control

0.995

[− 5.951, 7.934]

Naïve control—MPTP 5 mg/ml

 < 0.001 ***

[− 20.232, − 4.903]

Naïve control—NAM+ MPTP 5 mg/ml

1.000

[− 6.719, 7.166]

Naïve control—MPTP 50 mg/ml

 < 0.001 ***

[− 24.395, − 8.262]

Naïve control—NAM+ MPTP 50 mg/ml

0.546

[− 11.092, 3.635]

  1. Significance: *P < 0.05, **P < 0.01, ***P < 0.001